DANIELLE TODD: Open Payments
NPI 1457568610 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 12 payments from 7 companies in 2025. Trend: 2023 $313 · 2024 $403 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Alkermes, Inc. | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: ARISTADA, AUSTEDO XR, REXULTI, Auvelity, ABILIFY ASIMTUFII, COBENFY, CAPLYTA, INVEGA SUSTENNA.
Industry payments across NC — which companies pay providers there.
